Company Email Format Management

Elasmogen Ltd

Biotechnology Research 11 employees

Employees: 11
Contacts: 2
Emails: 2
Phones: 1

www.elasmogen.com LinkedIn Crunchbase

Elasmogen Ltd Overview

Website: www.elasmogen.com
Industry: Biotechnology Research
Employees: 11
Founded: 2016
Funding: 9.9M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Therapeutic biologics Autoimmune and Inflammatory disease antibody drug conjugate bispecific biologics dual targeting

About Elasmogen Ltd

Elasmogen is a therapeutic biologics company developing dual targeting products for difficult-to-treat autoimmune diseases. Our lead, first-in-class product, ELN28, is designed to target to the site of inflammation where it neutralises soluble TNFa whilst specifically and safely delivering Janus kinase inhibitor. Our mission is to progress ELN28 to the clinic, breaking the efficacy ceiling on current therapies, to treat autoimmune patients with poorly controlled disease by providing rapid control and long-term remission.

Elasmogen Ltd Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Elasmogen Ltd Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jane Dancer		Cambridge, England, United Kingdom	Email
Caroline Barelle	Chief Executive Officer and Founder		View
Andy Porter	Director		View
Obinna C Ubah	Lead Principal Scientist & Ukri Future	Greater Aberdeen Area, United Kingdom	Email Phone